| |
Fig S4. Analysis of secondary axis formation. Embryos were injected (1xV2) with 200 pg of LL-VP16-GR mRNA at the 8-cell stage. (A) In situ hybridization for pax8 of embryos at stage 31, followed by 12/101 whole-mount immunostaining. (A, C, E, G, I, K) Uninjected embryos. (B, D, F, H, J, L) Injected embryos. Activation of LL-VP16-GR was controlled by addition of dexamethasone (Dex) at specified stages. Dex was added to uninjected and injected embryos at: (A, B) stage 10; (C, D) stage 12.5; (E, F) stage 15; (G, H) stage 18; (I, J) stage 21; (K, L) stage 24. |
